$124.20
-13.81[-10.01%]
At close: Apr 26
$124.20
0[0.00%]
After Hours: 7:16PM EDT
Latest News for DexCom Stock (NASDAQ:DXCM)
DexCom Stock (NASDAQ: DXCM)
Categories: All
Friday, April 26, 2024
- Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - 2 days ago
- Raymond James Maintains Strong Buy on DexCom, Raises Price Target to $160Benzinga Newsdesk - 2 days ago
- Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $145Benzinga Newsdesk - 2 days ago
- Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving PremarketAvi Kapoor - 2 days ago
- DexCom shares are trading lower. The company reported Q1 financial results.Benzinga Newsdesk - 2 days ago
- Intel Reports Weak Sales, Joins Boyd Gaming, Atlassian And Other Big Stocks Moving Lower In Friday's Pre-Market SessionAvi Kapoor - 2 days ago
Thursday, April 25, 2024
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - 3 days ago
- Peering Into DexCom's Recent Short InterestBenzinga Insights - 3 days ago
- DexCom shares are trading lower. The company reported Q1 financial results.Benzinga Newsdesk - 3 days ago
- DexCom Sees FY24 Revenue $4.20B-$4.35B Vs $4.326B Est.Benzinga Newsdesk - 3 days ago
- DexCom Q1 2024 Adj EPS $0.32 Beats $0.27 Estimate, Sales $921.000M Beat $909.238M EstimateBenzinga Newsdesk - 3 days ago
Wednesday, April 17, 2024
Thursday, April 11, 2024
Wednesday, April 10, 2024
Monday, April 08, 2024
Wednesday, April 03, 2024
Monday, April 01, 2024
Monday, March 25, 2024
Wednesday, March 20, 2024
Monday, March 18, 2024
Thursday, March 14, 2024
Wednesday, March 13, 2024
Tuesday, March 12, 2024
- DexCom Is 'Expanding Rapidly' With Multi-Year Runway Ahead, Bullish Analyst SaysPriya Nigam - Mar 12, 2024, 11:54AM
- Analyst Expectations For DexCom's FutureBenzinga Insights - Mar 12, 2024, 8:01AM
- RBC Capital Initiates Coverage On DexCom with Outperform Rating, Announces Price Target of $165Benzinga Newsdesk - Mar 12, 2024, 7:40AM
Thursday, March 07, 2024
Wednesday, March 06, 2024
- FDA Approval For DexCom's Stelo Opens Continuous Glucose Monitoring To Masses, Analyst Expects Competitive Pricing Against Abbott'sVandana Singh - Mar 6, 2024, 4:48PM
- Stocks Surge, Gold Hits New All-Time High, Bitcoin Reclaims $67,000 As Powell Reassures Wall Street: What's Driving Markets Wednesday?Piero Cingari - Mar 6, 2024, 2:24PM
- CNBC Halftime Report Final Trades: SL Green Realty, Palantir Technologies And DexComBenzinga Newsdesk - Mar 6, 2024, 1:01PM
- FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without PrescriptionVandana Singh - Mar 6, 2024, 9:12AM
- DexCom shares are trading higher after the company announced FDA clearance of Stelo.Benzinga Newsdesk - Mar 6, 2024, 6:51AM
- Campbell Soup, Box And 3 Stocks To Watch Heading Into WednesdayAvi Kapoor - Mar 6, 2024, 2:28AM
Tuesday, March 05, 2024
Friday, March 01, 2024
Thursday, February 22, 2024
Wednesday, February 21, 2024
Friday, February 09, 2024
Thursday, February 08, 2024
- DexCom: Q4 Earnings InsightsBenzinga Insights - Feb 8, 2024, 4:10PM
- DexCom Sees FY24 Revenue $4.15B-$4.35B Vs $4.33B Est.Benzinga Newsdesk - Feb 8, 2024, 4:04PM
- DexCom Q4 EPS $0.50 Beats $0.43 Estimate, Sales $1.03B Beat $1.02B EstimateBenzinga Newsdesk - Feb 8, 2024, 4:03PM
- Behind the Scenes of DexCom's Latest Options TrendsBenzinga Insights - Feb 8, 2024, 11:16AM
- Earnings Scheduled For February 8, 2024Benzinga Insights - Feb 8, 2024, 4:43AM